Details:

About Glaxo - Investor Relations:

Glaxo - Investor Relations is located at 499 Park Ave in Midtown - New York, NY - New York County and is a business listed in the categories Financial Planning Consultants, Financial Planning, Investors, Nec, Financial Planning & Services and Portfolio Management. After you do business with Glaxo - Investor Relations, please leave a review to help other people and improve hubbiz. Also, don't forget to mention Hubbiz to Glaxo - Investor Relations.

Categories: Financial Planning Consultants, Financial Planning, Investors, Nec, Financial Planning & Services and Portfolio Management

Share:
Map & Directions:
Directions
Suggest a Tag:
  • Annuities
  • Auto Insurance
  • Banking
  • Bonds
  • Business Consulting
  • Business Planning
  • CFP
  • CPA
  • Defined Benefit
  • Disability Insurance
  • E-Services
  • Educational Planning
  • Equities
  • Estate Planning
  • Fee-Based Services
  • Financial Planning
  • Global Investments
  • Indexes
  • Individual Services
  • Inheritance Planning
  • IRAs
  • Life Insurance
  • Mutual Funds
  • Options
  • Personal Planning
  • Research
  • Retirement Planning
  • Rollover Plans
  • Savings
  • Securities
  • Small Business
  • Stocks
  • Tax Planning
  • Term Care
  • Trust Management
  • Trust Planning
  • Trust Services
  • Wealth Management
  • Wealth Planning

Please, help us improve the listing for Glaxo - Investor Relations.

We picked the most popular labels that other businesses under the category Financial Planning Consultants are using.

We would like to confirm which of them is featured by Glaxo - Investor Relations.

It doesn't require registration. But if you sign-up on Hubbiz, it will have more weight on our algorithms and in the future, we can, with your permission, inform the business that you helped improve their listing (in case they decide to show their appreciation).

There's no need to be perfect. A few more labels will already help other people find the right information.

We appreciate your contribution.

Reviews for Glaxo - Investor Relations: